Third Eye Diagnostics Overview

  • Founded
  • 2007

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $250K

  • Investors
  • 3

Third Eye Diagnostics General Information

Description

Developer of an intracranial pressure monitoring device designed to gather information from the patient's eye. The company offers a device that measures blood pressure in the eye's Central Retinal Vein (CRV) which correlates to intracranial pressure and simultaneously records images of the CRV, enabling physicians to treat patients with acute increases in ICP caused by severe head injury, intracranial hemorrhage, or stroke.

Contact Information

Website
www.3-e-d.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • 116 Research Drive
  • Lehigh University
  • Bethlehem, PA 18015
  • United States
+1 (215) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Third Eye Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 17-Aug-2015 $250K 00.000 Completed Generating Revenue
6. Later Stage VC 12-Sep-2013 00.000 00.000 Completed Generating Revenue
5. Grant 09-Aug-2013 00000 00000 Completed Generating Revenue
4. Early Stage VC 29-May-2009 0000 00000 Completed Startup
3. Accelerator/Incubator 17-Nov-2008 000 00000 Completed Startup
2. Debt - General 19-Mar-2008 $150K $150K Completed Startup
1. Seed Round 01-Feb-2008 Completed Startup
To view Third Eye Diagnostics’s complete valuation and funding history, request access »

Third Eye Diagnostics Patents

Third Eye Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10405763-B2 Devices and methods for noninvasive measurement of intracranial pressure Active 02-Dec-2011 000000000 00
US-20170188860-A1 Devices and methods for noninvasive measurement of intracranial pressure Active 02-Dec-2011 000000000 0
US-20150265172-A1 Devices and methods for noninvasive measurement of intracranial pressure Inactive 02-Dec-2011 000000000 0
US-20130144185-A1 Devices and methods for noninvasive measurement of intracranial pressure Active 02-Dec-2011 000000000 0
US-9078612-B2 Devices and methods for noninvasive measurement of intracranial pressure Active 02-Dec-2011 A61B3/16 00
To view Third Eye Diagnostics’s complete patent history, request access »

Third Eye Diagnostics Executive Team (4)

Name Title Board Seat Contact Info
Terry Fuller Ph.D Chief Executive Officer & Chairman
Mark Dorfman Chief Financial Officer
Anthony Bellezza Ph.D Co-Founder, Chief Operating Officer, President & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Third Eye Diagnostics Board Members (3)

Name Representing Role Since
Albert Woodward Self Board Member 000 0000
Anthony Bellezza Ph.D Third Eye Diagnostics Co-Founder, Chief Operating Officer, President & Board Member 000 0000
Terry Fuller Ph.D Third Eye Diagnostics Chief Executive Officer & Chairman 000 0000
To view Third Eye Diagnostics’s complete board members history, request access »

Third Eye Diagnostics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lehigh Valley Economic Development Corporation Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Ben Franklin Technology Partners of Northeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
To view Third Eye Diagnostics’s complete investors history, request access »